BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34562372)

  • 1. Oncogene-dependent sloppiness in mRNA translation.
    Champagne J; Pataskar A; Blommaert N; Nagel R; Wernaart D; Ramalho S; Kenski J; Bleijerveld OB; Zaal EA; Berkers CR; Altelaar M; Peeper DS; Faller WJ; Agami R
    Mol Cell; 2021 Nov; 81(22):4709-4721.e9. PubMed ID: 34562372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumour immunity induces aberrant peptide presentation in melanoma.
    Bartok O; Pataskar A; Nagel R; Laos M; Goldfarb E; Hayoun D; Levy R; Körner PR; Kreuger IZM; Champagne J; Zaal EA; Bleijerveld OB; Huang X; Kenski J; Wargo J; Brandis A; Levin Y; Mizrahi O; Alon M; Lebon S; Yang W; Nielsen MM; Stern-Ginossar N; Altelaar M; Berkers CR; Geiger T; Peeper DS; Olweus J; Samuels Y; Agami R
    Nature; 2021 Feb; 590(7845):332-337. PubMed ID: 33328638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting.
    Champagne J; Mordente K; Nagel R; Agami R
    Trends Genet; 2022 Nov; 38(11):1123-1133. PubMed ID: 35641342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome diversification by mRNA translation in cancer.
    Kochavi A; Lovecchio D; Faller WJ; Agami R
    Mol Cell; 2023 Feb; 83(3):469-480. PubMed ID: 36521491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosome collisions alter frameshifting at translational reprogramming motifs in bacterial mRNAs.
    Smith AM; Costello MS; Kettring AH; Wingo RJ; Moore SD
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21769-21779. PubMed ID: 31591196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asc1, homolog of human RACK1, prevents frameshifting in yeast by ribosomes stalled at CGA codon repeats.
    Wolf AS; Grayhack EJ
    RNA; 2015 May; 21(5):935-45. PubMed ID: 25792604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma.
    Gao MZ; Wang HB; Chen XL; Cao WT; Fu L; Li Y; Quan HT; Xie CY; Lou LG
    Acta Pharmacol Sin; 2019 Feb; 40(2):268-278. PubMed ID: 29777202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between mechanical strength of messenger RNA pseudoknots and ribosomal frameshifting.
    Hansen TM; Reihani SN; Oddershede LB; Sørensen MA
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5830-5. PubMed ID: 17389398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA-Mediated Duplexes Play Dual Roles in the Regulation of Bidirectional Ribosomal Frameshifting.
    Huang WP; Cho CP; Chang KY
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed +1 frameshifting stimulated by complementarity between a downstream mRNA sequence and an error-correcting region of rRNA.
    Li Z; Stahl G; Farabaugh PJ
    RNA; 2001 Feb; 7(2):275-84. PubMed ID: 11233984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The energy landscape of -1 ribosomal frameshifting.
    Choi J; O'Loughlin S; Atkins JF; Puglisi JD
    Sci Adv; 2020 Jan; 6(1):eaax6969. PubMed ID: 31911945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosome Collisions Result in +1 Frameshifting in the Absence of No-Go Decay.
    Simms CL; Yan LL; Qiu JK; Zaher HS
    Cell Rep; 2019 Aug; 28(7):1679-1689.e4. PubMed ID: 31412239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth.
    Romeo Y; Moreau J; Zindy PJ; Saba-El-Leil M; Lavoie G; Dandachi F; Baptissart M; Borden KLB; Meloche S; Roux PP
    Oncogene; 2013 Jun; 32(24):2917-2926. PubMed ID: 22797077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic interventions to disrupt the protein synthetic machinery in melanoma.
    Kardos GR; Robertson GP
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):501-19. PubMed ID: 26139519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma.
    Yadav V; Zhang X; Liu J; Estrem S; Li S; Gong XQ; Buchanan S; Henry JR; Starling JJ; Peng SB
    J Biol Chem; 2012 Aug; 287(33):28087-98. PubMed ID: 22730329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma.
    Leung GP; Feng T; Sigoillot FD; Geyer FC; Shirley MD; Ruddy DA; Rakiec DP; Freeman AK; Engelman JA; Jaskelioff M; Stuart DD
    Mol Cancer Res; 2019 Jan; 17(1):199-211. PubMed ID: 30201825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changed in translation: mRNA recoding by -1 programmed ribosomal frameshifting.
    Caliskan N; Peske F; Rodnina MV
    Trends Biochem Sci; 2015 May; 40(5):265-74. PubMed ID: 25850333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.
    Bradley SD; Chen Z; Melendez B; Talukder A; Khalili JS; Rodriguez-Cruz T; Liu S; Whittington M; Deng W; Li F; Bernatchez C; Radvanyi LG; Davies MA; Hwu P; Lizée G
    Cancer Immunol Res; 2015 Jun; 3(6):602-9. PubMed ID: 25795007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein.
    Liston P; Briedis DJ
    J Virol; 1995 Nov; 69(11):6742-50. PubMed ID: 7474085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ribosomal frameshifting error during translation of the argI mRNA of Escherichia coli.
    Fu C; Parker J
    Mol Gen Genet; 1994 May; 243(4):434-41. PubMed ID: 7515462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.